If you need more lookups,
subscriptions start at $34 USD/month.
Hadas Nachmanson Location
Israel
Hadas Nachmanson Work
Founder and CEO @ (November 2024 - Present)
Clinical Trial Manager | Global Phase I–II Oncology Trials @ (February 2023 - November 2024)
Clinical Project Manager | Global Phase I–III Clinical Trials @ (February 2021 - October 2022)
Clinical Research Associate @ (March 2020 - March 2021)
Clinical Trial Assistant @ (September 2018 - February 2020)
Clinical Research Coordinator @ (July 2017 - September 2018)
Hadas Nachmanson Education
Tel-Hai University of Kiryat Shmona in the Galilee
Bachelor of Applied Science - BS.c (Biotechnology)
2012-2015
Hadas Nachmanson Skills
Artificial Intelligence (AI)
CRO
CRO Oversight
CRO and Vendor Oversight
Clinical Data Management
Clinical Operations
Clinical Research Associates (CRA)
Clinical Trial Oversight
Clinical trial manager
Decentralized Clinical Trial
GCP ICH guidelines
Good Clinical Practice (GCP)
IRT Systems
Investigational Medicinal Product (IMP)
Oncology Clinical Trials
Protocol Compliance
Remote Monitoring
Site Management
Trial Management
Vendor Management
logistics solutions for IMP
Hadas Nachmanson Summary
Hadas Nachmanson, based in Israel, is currently a Founder and CEO at MYRTLE CLINICAL. Hadas Nachmanson brings experience from previous roles at Purple Biotech, SciVac Limited, Mileutis Ltd. and Novartis. Hadas Nachmanson holds a 2012 - 2015 Bachelor of Applied Science - BS.c in Biotechnology @ Tel-Hai University of Kiryat Shmona in the Galilee. With a robust skill set that includes Artificial Intelligence (AI), CRO, CRO Oversight, CRO and Vendor Oversight, Clinical Data Management and more. Hadas Nachmanson has 1 emails on RocketReach.
Looking for a different Hadas Nachmanson?
Find contact details for 700 million professionals.